Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the predictive biomarkers market grown over the years?

Over the past few years, there has been a noticeable expansion of the predictive biomarkers market. The market, which was valued at $20.05 billion in 2024, is expected to increase to $20.96 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%. The significant growth during the historic period was a result of factors such as escalated research and development investments, the broadening of healthcare infrastructure, beneficial partnerships between academia and the commercial sector, a rising prevalence of cancer and genetic conditions, and the increased employment of biomarkers in the development of drugs.

What Is the forecasted market size and growth rate for the predictive biomarkers market?

The market for predictive biomarkers is anticipated to experience consistent expansion in the coming years, ultimately reaching a value of $24.67 billion in 2029, with a compound annual growth rate (CAGR) of 4.2%. The projected growth during this period can be ascribed to factors like the growing embrace of precision medicine, increased focus on preventative healthcare, elevated health expenditure, larger investment in diagnostics based on biomarkers, growth of biobanks and tissue repositories, along with an upsurge in global health consciousness. Some emerging trends for the forecast period encompass the incorporation of artificial intelligence in biomarker analysis, progression in non-invasive biomarker testing, advancements in digital health tools centered around biomarkers, progress in single-cell sequencing technologies, evolution of real-time biosensing and monitoring systems, and the advancement in bioinformatics tools meant for data integration.

Get your predictive biomarkers market report here!

https://www.thebusinessresearchcompany.com/report/predictive-biomarkers-global-market-report

What are the major factors driving growth in the predictive biomarkers market?

The increasing incidence of cancer is projected to spur the expansion of the predictive biomarkers market. Defined by rampant cell growth that has the potential to infiltrate and spread throughout the body, cancer’s escalating rates are largely attributed to aging populations, shifts in lifestyle, and heightened exposure to risk factors including tobacco, unhealthy eating habits, and environmental pollutants. Predictive biomarkers play a vital role in cancer treatment by identifying patients likely to benefit from certain treatments, thereby facilitating customized and more efficient therapy. For example, a report from the International Agency for Research on Cancer (IARC), a France-based specialized agency of the World Health Organization (WHO) specializing in cancer research, stated that in April 2024, nearly 20 million new cancer cases and about 10 million cancer-related deaths were reported in 2022. Furthermore, estimates indicate that the yearly count of new cancer diagnoses will increase to 35 million by 2050, showing a 77% surge from 2022 figures. Hence, the growing cancer incidence is expected to fuel the expansion of the predictive biomarkers market.

What key areas define the segmentation of the global predictive biomarkers Market?

The predictive biomarkers market covered in this report is segmented –

1) By Indication: Cancer, Metabolic Disease, Cardiovascular Disorder, Immunological Disorder, Other Indications

2) By Application: Screening, Analysis, Diagnosis, Prediction, Monitoring

3) By End User: Diagnostic Centers, Contract Research Organizations, Academic Research Institutes, Pharms And Biotech Companies, Other End Users

Subsegments:

1) By Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, Leukemia And Lymphoma, Melanoma, Pancreatic Cancer, Kidney Cancer, Head And Neck Cancer

2) By Metabolic Disease: Type 1 and Type 2 Diabetes, Obesity, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD), Dyslipidemia, Insulin Resistance

3) By Cardiovascular Disorder: Atherosclerosis, Coronary Artery Disease, Heart Failure, Myocardial Infarction (Heart Attack), Arrhythmia, Hypertension, Stroke, Peripheral Arterial Disease

4) By Immunological Disorder: Autoimmune Diseases, Inflammatory Bowel Disease (IBD), Multiple Sclerosis, Psoriasis, Allergic Diseases, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Immunodeficiency Disorders

5) By Other Indications: Neurological Disorders, Infectious Diseases, Renal Diseases, Osteoarthritis, Genetic Disorders, Respiratory Disorders

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20595&type=smp

What are the top market players propelling the growth of the predictive biomarkers industry?

Major companies operating in the predictive biomarkers market are Johnson & Johnson Services Inc, F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthcare GmbH, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Bio-Rad Laboratories Inc, QIAGEN GmbH, Almac Group Limited, ArcherDX Inc, Luminex Corporation, Guardant Health Inc, Meso Scale Diagnostics LLC, Myriad Genetics Inc, NanoString Technologies Inc, Fujirebio Inc, Asuragen Inc, Biognosys AG, Epigenomics AG, OncoCyte Corporation, Biomarker Technologies Inc

What are the key trends shaping the future of the predictive biomarkers market?

Top firms in the predictive biomarkers sector are putting efforts into driving biomarker innovation by integrating advances in technology, like AI-based biomarker identification, to gain market advantages by providing quicker, more personalized, and effective treatment solutions. The use of AI in biomarker discovery opens up the opportunity for analyzing substantial complex data, thus facilitating the detection of predictive biomarkers that may not be visible using conventional approach. For instance, in July 2024, a precision immunology firm based in the US – Scipher Medicine, Inc., initiated PRoBeNet (Predictive Response Biomarkers using Network Medicine) aimed at speeding up the creation of predictive response biomarkers for intricate diseases utilizing network biology and AI. PRoBeNet distinguishes therapy response biomarkers by amalgamating proteins targeted for therapy and disease-specific molecular patterns. The system has been tested and approved for autoimmune illnesses such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis, and it can be implemented on other complicated diseases and phases of drug development.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20595

What regions are dominating the predictive biomarkers market growth?

North America was the largest region in the predictive biomarkers market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Cancer Biomarker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: